Burden of type 2 diabetes in Asia‐Pacific regions, 1990–2021: <scp>GBD</scp> 2021 analysis with forecast to 2050
Asia's diabetes burden has continued to increase, driven by population growth, ageing and epidemiological shifts. Targeted prevention, healthcare access and ageing policies are critical, especially in high-burden regions like South and Central Asia.
Authors
- Sheng Zhang (ORCID: https://orcid.org/0000-0001-5258-8545)
- Yinghe Xu
- Yongpo Jiang
- Hongyu Wang
- Weimin Zhu
- Xin Wang
- Renfei Shan
- Ting Xu
Institutions
- Wenzhou Medical University (CN)
- Fifth Affiliated Hospital of Zhengzhou University (CN)
- Zhejiang Lab (CN)
- Zhejiang Taizhou Hospital (CN)
- Taizhou University (CN)
Publication Details
- Journal
- Diabetic Medicine
- Published
- 2026-01-06
- DOI
- https://doi.org/10.1111/dme.70216
- Primary Topic
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China
- National Key Research and Development Program of China
- Natural Science Foundation of Zhejiang Province